Ashley Gallagher, MA

Investigators of the multicenter cohort aim to determine if the 13-valent pneumococcal conjugate vaccine impacted disease activity over a 24-month period.

A growing body of evidence suggests that the choice of glucose-lowering therapy may play a critical role in colorectal cancer prevention.

Ulcers represent one of the most serious and costly complications of diabetes characterized by a high risk of recurrence.

Wounds are defined as disruptions of tissue integrity that can occur in the skin, mucous membranes, or internal organs, often accompanied by pain and infection risks.

Pharmacists spot diabetes risk early, explain heart- and kidney-protecting meds, decode CGM data, and find affordable support.

Orforglipron is the first new molecular entity to be cleared under the FDA Commissioner's National Priority Voucher pilot program.

Timothy Aungst, PharmD, and Ravi Patel, PharmD, MBA, MS, unpack the role of direct-to-patient in the current pharmacy landscape.

The question facing many independents is no longer whether vaccines matter but whether a vaccine program is truly right for their pharmacy.

This study indicates that stopping the medication is noninferior to continuing it indefinitely in terms of preventing death, recurrent heart attacks, or hospitalizations.

This benefit was primarily driven by significant reductions in nonfatal heart attacks and the need for revascularization procedures.

The study demonstrated that providing a combination of produce prescriptions, dietitian coaching, and artificial intelligence-optimized encouragement led to improved cardiovascular outcomes.

The biosimilar is approved for all indications of the reference product, including the treatment of postmenopausal women with osteoporosis at high risk for fracture.

As population-level introduction of pneumococcal conjugate vaccines has led to an increase in invasive disease, the development of higher-valency vaccines has become a primary solution.

Serotype 19F resurges despite PCVs, raising invasive disease risk in older adults; pharmacists track immune evasion, variants, and boost adherence.

The FDA approves removing the age requirement for epinephrine nasal spray (neffy) 1 mg, effectively allowing all children and adults who weigh 33 pounds.

These guidelines serve as a comprehensive guideline that prioritizes earlier intervention through lifestyle optimization and lower treatment targets for those at highest risk.

Awiqli represents a significant shift in the treatment landscape, potentially reducing the burden of basal insulin administration from 365 injections a year to 52.

A new study suggests that even though the profession is at a crossroads, the path toward improvement depends heavily on the setting in which a pharmacist practices.

Pharmacists can build trust in buprenorphine care, handle early refill red flags, and point patients to resources to help them with substance use disorder.

New Glycemia Risk Index data shows continuous glucose monitoring cuts hypo- and hyperglycemia risk in type 1 diabetes, giving pharmacists a faster way to estimate control.

Phase 3 data show a 6-valent Lyme vaccine cuts confirmed cases by 73%, paving the way for 2026 filings and new prevention options.

Harm reduction for pharmacists can include person-first language and stigma-free naloxone counseling that keeps patients with substance use disorder safer.

New study links basal‑prandial insulin to healthier remnant cholesterol in type 2 diabetes, spotlighting hidden cardiovascular risk beyond low-density lipoprotein and A1c.

Many patients struggle with the everyday realities of staying on the medication, which can include uncomfortable adverse effects.

Lilly’s once-weekly retatrutide lowers A1C up to 2% and drives nearly 17% weight loss in type 2 diabetes, signaling a powerful triple-agonist shift.

The SUPPORT Act 2025 lets pharmacists prescribe buprenorphine for opioid use disorder, but DEA training and state rules shape access and new formulations.

Mississippi pharmacies strengthen prenatal care with monthly check-ins, vitamins, aspirin, screenings, and community support for high-risk moms.

Across the United States, trafficking also takes the form of labor exploitation in farms, factories, and remote industrial regions.

MAHA-driven HHS shifts vaccines and nutrition, fueling public health debate as pharmacists battle social media misinformation and rebuild trust.

The FDA clears the highest-dose weekly semaglutide for obesity, showing 20.7% mean weight loss with the same blood sugar-lowering effects.